Search

everythinglearnresearchcommunity

for

Search:↓

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

Pumpkin seed oil slightly outperforms minoxidil foam in treating hair loss with fewer side effects.

A 12-year-old boy with a rare genetic condition has progressive hair loss with no effective treatment.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Certain Prakruti types are more prone to early male pattern baldness.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Combining minoxidil and spironolactone is more effective for female hair loss, but minoxidil alone is sufficient after 6 months.

People with chronic hair loss often have lower Vitamin B12 levels.

Topical minoxidil is the primary treatment for female pattern hair loss in India.

The supplement helps improve hair growth and reduce hair shedding.

Natural products show promise for new hair loss treatments.

Minoxidil 2% is more effective for female hair loss, but botanicals have fewer side effects.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

A man with HIV had hair loss due to syphilis, which improved after penicillin treatment.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

A 35-year-old man had patchy hair loss that was actually due to syphilis, not alopecia areata.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Propionibacterium acnes might be linked to hair casts and possibly alopecia.

Low dose valproic acid treatment caused hair loss in a young patient.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.